跳至主要内容
临床试验/NCT00708539
NCT00708539Unknown4 期

A Prospective Randomized Multicentre Study to Compare Crinone 8% Once Daily Versus Other Vaginal Progesterone.

Nordica Fertility Clinic17 个研究点 分布在 2 个国家目标入组 2,686 人开始时间: 2006年4月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
发起方
入组人数
2,686
试验地点
17
主要终点
Equivalence in ongoing pregnancy per embryo transfer between the two groups

研究概览

简要总结

To compare the effect of Crinone 8% administered once daily versus other vaginal progesterone in terms of ongoing pregnancy rate 5 weeks after embryo transfer as well as patient convenience.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • 18-40 years
  • Regular menstrual cyclus 25-35 days
  • both ovaries present
  • No more than 2 previous IVF attempts
  • Have given written informed consent

排除标准

  • More than 2 previous attempts
  • Known drug abuse
  • Known allergies to the study medication
  • No embryo transfer performed in the study cycle
  • Previous participating in the study

研究组 & 干预措施

1

Active Comparator

Crinone vaginal gel 8% 90 mg once daily

干预措施: Progesterone (Drug)

2

Active Comparator

Progesterone mic 400 mg three times daily

干预措施: Progesterone (Drug)

结局指标

主要结局

Equivalence in ongoing pregnancy per embryo transfer between the two groups

时间窗: week 5 after embryo tranfer

次要结局

  • Convenience for the patient(the treatment period (from the day of embryo transfer and 19 days ahead))

研究者

发起方
Nordica Fertility Clinic
申办方类型
Other

研究点 (17)

Loading locations...

相似试验